OBJECTIVE: To determine the effectiveness of brief strategic family therapy (BSFT; an evidence-based family therapy) compared to treatment as usual (TAU) as provided in community-based adolescent outpatient drug abuse programs. METHOD: A randomized effectiveness trial in the National Drug Abuse Treatment Clinical Trials Network compared BSFT to TAUwith a multiethnic sample of adolescents (213 Hispanic, 148 White, and 110 Black) referred for drug abuse treatment at 8 community treatment agencies nationwide. Randomization encompassed both adolescents' families (n = 480) and the agency therapists (n = 49) who provided either TAU or BSFT services. The primary outcome was adolescent drug use, assessed monthly via adolescent self-report and urinalysis for up to 1 year post randomization. Secondary outcomes included treatment engagement (≥2 sessions), retention (≥8 sessions), and participants' reports of family functioning 4, 8, and 12 months following randomization. RESULTS: No overall differences between conditions were observed in the trajectories of self-reports of adolescent drug use. However, the median number of days of self-reported drug use was significantly higher, χ2(1) = 5.40, p < .02, in TAU (Mdn = 3.5, interquartile range [IQR] = 11) than BSFT (Mdn = 2, IQR = 9) at the final observation point. BSFT was significantly more effective than TAU in engaging, χ2(1) = 11.33, p < .001, and retaining, χ2(1) = 5.66, p < .02, family members in treatment and in improving parent reports of family functioning, χ2(2) = 9.10, p < .011. CONCLUSIONS: We discuss challenges in treatment implementation in community settings and provide recommendations for further research.
RCT Entities:
OBJECTIVE: To determine the effectiveness of brief strategic family therapy (BSFT; an evidence-based family therapy) compared to treatment as usual (TAU) as provided in community-based adolescent outpatientdrug abuse programs. METHOD: A randomized effectiveness trial in the National Drug Abuse Treatment Clinical Trials Network compared BSFT to TAU with a multiethnic sample of adolescents (213 Hispanic, 148 White, and 110 Black) referred for drug abuse treatment at 8 community treatment agencies nationwide. Randomization encompassed both adolescents' families (n = 480) and the agency therapists (n = 49) who provided either TAU or BSFT services. The primary outcome was adolescent drug use, assessed monthly via adolescent self-report and urinalysis for up to 1 year post randomization. Secondary outcomes included treatment engagement (≥2 sessions), retention (≥8 sessions), and participants' reports of family functioning 4, 8, and 12 months following randomization. RESULTS: No overall differences between conditions were observed in the trajectories of self-reports of adolescent drug use. However, the median number of days of self-reported drug use was significantly higher, χ2(1) = 5.40, p < .02, in TAU (Mdn = 3.5, interquartile range [IQR] = 11) than BSFT (Mdn = 2, IQR = 9) at the final observation point. BSFT was significantly more effective than TAU in engaging, χ2(1) = 11.33, p < .001, and retaining, χ2(1) = 5.66, p < .02, family members in treatment and in improving parent reports of family functioning, χ2(2) = 9.10, p < .011. CONCLUSIONS: We discuss challenges in treatment implementation in community settings and provide recommendations for further research.
Authors: C P Lucas; H Zhang; P W Fisher; D Shaffer; D A Regier; W E Narrow; K Bourdon; M K Dulcan; G Canino; M Rubio-Stipec; B B Lahey; P Friman Journal: J Am Acad Child Adolesc Psychiatry Date: 2001-04 Impact factor: 8.829
Authors: Michael Dennis; Susan H Godley; Guy Diamond; Frank M Tims; Thomas Babor; Jean Donaldson; Howard Liddle; Janet C Titus; Yifrah Kaminer; Charles Webb; Nancy Hamilton; Rod Funk Journal: J Subst Abuse Treat Date: 2004-10
Authors: D Shaffer; P Fisher; M K Dulcan; M Davies; J Piacentini; M E Schwab-Stone; B B Lahey; K Bourdon; P S Jensen; H R Bird; G Canino; D A Regier Journal: J Am Acad Child Adolesc Psychiatry Date: 1996-07 Impact factor: 8.829
Authors: Michael S Robbins; Daniel J Feaster; Viviana E Horigian; Marc J Puccinelli; Craig Henderson; José Szapocznik Journal: J Consult Clin Psychol Date: 2011-02
Authors: Daniel J Feaster; Michael S Robbins; Craig Henderson; Viviana Horigian; Marc J Puccinelli; A Kathy Burlew; José Szapocznik Journal: J Subst Abuse Treat Date: 2010-06
Authors: Michael S Robbins; Elizabeth Alonso; Viviana E Horigian; Ken Bachrach; Kathy Burlew; Ibis S Carrión; Candace C Hodgkins; Michael Miller; Eric Schindler; Nancy VanDeMark; Craig Henderson; José Szapocznik Journal: Addict Sci Clin Pract Date: 2010-12
Authors: Kimberly H McManama O'Brien; Jonathan B Singer; Mary LeCloux; Yovanska Duarté-Vélez; Anthony Spirito Journal: Int J Behav Consult Ther Date: 2014